730PA pilot study of gemcitabine, nab-paclitaxel, PEGPH20...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

730PA pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis

Yu, K, Mantha, S, Tjan, C, Kaufmann, E, Brenner, R B, Lowery, M, Ku, G, Raj, N, Shcherba, M, Goldberg, Z, Li, J, Zervoudakis, A, Hamilton, A, Won, E, Do, R K G, O’Reilly, E M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.113
Date:
October, 2018
File:
PDF, 87 KB
2018
Conversion to is in progress
Conversion to is failed